Ovarian cancer study identifies key genes for potential treatments
New research is increasing our understanding about why some women with the most lethal form…
Browsing: ovarian cancer
ASCO 2023: New drug combination twice as effective for some ovarian cancer patients as next best treatment
A targeted drug combination for patients with a type of ovarian cancer could be nearly twice as…
ASCO 2023: Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer
Updated dose expansion data of the phase I STRO-002-GM1 study were presented today by Ana Oaknin, Principal…
Study highlights racial disparities in ovarian cancer risk for women
A new Fred Hutchinson Cancer Center study in the journal Obstetrics & Gynecology investigated how endometriosis, uterine…
HRD detection predicts sensitivity to platinum-based chemotherapy for ovarian cancer patients in China
Homologous Recombination Deficiency (HRD) is a biomarker that predicts ovarian cancer treatment with PARP inhibitors…
We need to talk about ovarian cancer, our deadliest gynaecological cancer
We must urgently increase research funding and awareness of ovarian cancer if we want to…
ICR-discovered drug to enter phase II clinical trial in ovarian cancer thanks to new research collaboration
An innovative cancer drug discovered by scientists at The Institute of Cancer Research, London, UK,…
Researchers identify promising new target for drug-resistant breast and ovarian cancers
CU Boulder researchers have discovered a protein’s crucial role in helping breast and ovarian tumours…
Risks of removing ovaries at benign hysterectomy may outweigh the benefits for women at low risk for ovarian cancer
An emulated target trial of more than 140,000 women in Denmark found that removing the…
Researchers present a new approach to the treatment of ovarian cancer using RNA-based nanodrugs
In a study conducted at Tel Aviv University the protein CKAP5 (cytoskeleton-associated protein) was used…